SAKAR

Sakar Healthcare Share Price

 

Stock touched 52W high

 

Start SIP in SAKAR

Start SIP

Performance

  • Low
  • ₹419
  • High
  • ₹444
  • 52 Week Low
  • ₹210
  • 52 Week High
  • ₹444
  • Open Price₹431
  • Previous Close₹422
  • Volume88,148

Investment Returns

  • Over 1 Month + 5.53%
  • Over 3 Month + 26.34%
  • Over 6 Month + 35.11%
  • Over 1 Year + 32.81%

Smart Investing Starts Here Start SIP with Sakar Healthcare for Steady Growth!

Invest Now

Sakar Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 48.2
  • PEG Ratio
  • 0.8
  • Market Cap Cr
  • 940
  • P/B Ratio
  • Average True Range
  • 19.25
  • EPS
  • 8.79
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.29
  • RSI
  • 65.95
  • MFI
  • 83.03

Sakar Healthcare Financials

Sakar Healthcare Technicals

EMA & SMA

Current Price
₹422.35
+ 0.6 (0.14%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹389.01
  • 50 Day
  • ₹376.91
  • 100 Day
  • ₹361.72
  • 200 Day
  • ₹343.08

Resistance and Support

428.42 Pivot Speed
  • R3 463.93
  • R2 454.12
  • R1 438.23
  • S1 412.53
  • S2 402.72
  • S3 386.83

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sakar Healthcare has an operating revenue of Rs. 203.96 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 12% is healthy, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 19%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 12% and 29% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 55 which is a POOR score indicating inconsistency in earnings, a RS Rating of 91 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 112 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sakar Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-07 Quarterly Results & Others To consider other business matters.
2025-07-25 Quarterly Results & Others To consider other business matters.
2025-05-15 Audited results
2025-02-08 Quarterly Results
2024-10-22 Quarterly Results

Sakar Healthcare F&O

Sakar Healthcare Shareholding Pattern

52.86%
13.31%
16.02%
17.81%

About Sakar Healthcare

  • NSE Symbol
  • SAKAR
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Sanjay S Shah
  • ISIN
  • INE732S01012

Similar Stocks to Sakar Healthcare

Sakar Healthcare FAQs

Sakar Healthcare share price is ₹422 As on 14 December, 2025 | 03:54

The Market Cap of Sakar Healthcare is ₹939.7 Cr As on 14 December, 2025 | 03:54

The P/E ratio of Sakar Healthcare is 48.2 As on 14 December, 2025 | 03:54

The PB ratio of Sakar Healthcare is 3.5 As on 14 December, 2025 | 03:54

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23